Fuller & Thaler Asset Management
VIVO

Fuller & Thaler Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Fuller & Thaler Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-524,904
Closed -$17.4M – 556
2022
Q4 		$17.4M Sell
524,904
-12,916
-2% -$416K 0.11% 168
2022
Q3 		$17M Sell
537,820
-5,449
-1% -$176K 0.12% 169
2022
Q2 		$16.5M Buy
543,269
+84,492
+18% +$2.29M 0.11% 175
2022
Q1 		$11.9M Buy
458,777
+3,112
+0.7% +$74K 0.07% 214
2021
Q4 		$9.3M Buy
455,665
+256,729
+129% +$4.92M 0.05% 241
2021
Q3 		$3.83M Sell
198,936
-1,496,815
-88% -$29.8M 0.02% 274
2021
Q2 		$37.6M Buy
1,695,751
+54,351
+3% +$1.15M 0.24% 122
2021
Q1 		$43.1M Buy
1,641,400
+60,583
+4% +$1.44M 0.3% 106
2020
Q4 		$29.5M Buy
1,580,817
+387,466
+32% +$7.23M 0.27% 112
2020
Q3 		$20.3M Buy
1,193,351
+92,288
+8% +$1.79M 0.26% 112
2020
Q2 		$25.6M Buy
1,101,063
+1,099,413
+66,631% +$15.9M 0.34% 91
2020
Q1 		$14K Hold
1,650
– – ﹤0.01% 454
2019
Q4 		$16K Hold
1,650
– – ﹤0.01% 447
2019
Q3 		$16K Hold
1,650
– – ﹤0.01% 452
2019
Q2 		$20K Hold
1,650
– – ﹤0.01% 427
2019
Q1 		$29K Hold
1,650
– – ﹤0.01% 397
2018
Q4 		$29K Hold
1,650
– – ﹤0.01% 391
2018
Q3 		$25K Hold
1,650
– – ﹤0.01% 392
2018
Q2 		$26K Hold
1,650
– – ﹤0.01% 715
2018
Q1 		$23K Hold
1,650
– – ﹤0.01% 716
2017
Q4 		$23K Buy
1,650
+600
+57% +$8.78K ﹤0.01% 688
2017
Q3 		$15K Hold
1,050
– – ﹤0.01% 660
2017
Q2 		$17K Hold
1,050
– – ﹤0.01% 657
2017
Q1 		$14K Hold
1,050
– – ﹤0.01% 680
2016
Q4 		$19K Hold
1,050
– – ﹤0.01% 690
2016
Q3 		$20K Buy
+1,050
New +$20.5K ﹤0.01% 706

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fuller & Thaler Asset Management's VIVO Position: Q1 2023 in Review

Fuller & Thaler Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 524,904 shares — an estimated $17.4M sold.

Fuller & Thaler Asset Management first reported a position in VIVO in Q3 2016 and held it in 26 quarters. The position peaked at $43.1M in Q1 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Fuller & Thaler Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 524,904 Meridian Bioscience Inc shares in Q1 2023, an estimated $17.4M.
  • Fuller & Thaler Asset Management first reported a position in Meridian Bioscience Inc in Q3 2016 and held it in 26 quarters.
  • Fuller & Thaler Asset Management's Meridian Bioscience Inc position peaked at $43.1M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2023, filed 15 May 2023.